您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[美股财报]:美华国际2022年度报告 - 发现报告
当前位置:首页/财报/招股书/报告详情/

美华国际2022年度报告

2023-04-14美股财报北***
美华国际2022年度报告

UNITEDSTATES SECURITIESANDEXCHANGECOMMISSIONWASHINGTON,D.C.20549 FORM20-F (MarkOne) ☐REGISTRATIONSTATEMENTPURSUANTTOSECTION12(b)OR12(g)OFTHESECURITIESEXCHANGEACTOF1934 OR ☒ANNUALREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 ForthefiscalyearendedDecember31,2022OR ☐TRANSITIONREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 Forthetransitionperiodfromto OR ☐SHELLCOMPANYREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 Dateofeventrequiringthisshellcompanyreport:Commissionfilenumber:001-41291 MEIHUAINTERNATIONALMEDICALTECHNOLOGIESCO.,LTD. (ExactNameofRegistrantasSpecifiedinItsCharter) NotApplicable (TranslationofRegistrant’sNameIntoEnglish) CaymanIslands (JurisdictionofIncorporationorOrganization) 88TongdaRoad,TouqiaoTownGuanglingDistrict,Yangzhou,225000People’sRepublicofChina (AddressofPrincipalExecutiveOffices) XinWang,ChiefExecutiveOfficer88TongdaRoad,TouqiaoTown GuanglingDistrict,Yangzhou,225000People’sRepublicofChina Tel:+86-0514-89800199 secretary@meihuamed.com (Name,Telephone,E-mailand/orFacsimilenumberandAddressofCompanyContactPerson) SecuritiesregisteredortoberegisteredpursuanttoSection12(b)oftheAct: TitleofEachClassTradingSymbol(s) NameofEachExchangeOnWhichRegistered OrdinaryShare,$0.0005parvalueMHUANasdaqGlobalMarket SecuritiesregisteredortoberegisteredpursuanttoSection12(g)oftheAct. None(TitleofClass) SecuritiesforwhichthereisareportingobligationpursuanttoSection15(d)oftheAct. None(TitleofClass) Indicatethenumberofoutstandingsharesofeachoftheissuer’sclassesofcapitalorcommonstockasofthecloseoftheperiodcoveredbytheannualreport(December31,2022):23,940,000 Indicatebycheckmarkiftheregistrantisawell-knownseasonedissuer,asdefinedinRule405oftheSecuritiesAct.Yes☐No☒ Ifthisreportisanannualortransitionreport,indicatebycheckmarkiftheregistrantisnotrequiredtofilereportspursuanttoSection13or15(d)oftheSecuritiesExchangeActof1934.Yes☐No☒ Indicatebycheckmarkwhethertheregistrant(1)hasfiledallreportsrequiredtobefiledbySection13or15(d)oftheSecuritiesExchangeActof1934duringthepreceding12months(orforsuchshorterperiodthattheregistrantwasrequiredtofilesuchreports),and(2)hasbeensubjecttosuchfilingrequirementsforthepast90days.Yes☒No☐ IndicatebycheckmarkwhethertheregistranthassubmittedelectronicallyeveryInteractiveDataFilerequiredtobesubmittedpursuanttoRule405ofRegulationS-T(§232.405ofthischapter)duringthepreceding12months(orforsuchshorterperiodthattheregistrantwasrequiredtosubmitsuchfiles)Yes☒No☐ Indicatebycheckmarkwhethertheregistrantisalargeacceleratedfiler,anacceleratedfiler,anon-acceleratedfiler,oranemerginggrowthcompany.Seedefinitionof“largeacceleratedfiler,”“acceleratedfiler,”and“emerginggrowthcompany”inRule12b-2oftheExchangeAct. LargeacceleratedFiler ☐Acceleratedfiler☐Non-accelerated Filer ☒Emerginggrowth☒ company IfanemerginggrowthcompanythatpreparesitsfinancialstatementsinaccordancewithU.S.GAAP,indicatebycheckmarkiftheregistranthaselectednottousetheextendedtransitionperiodforcomplyingwithanyneworrevisedfinancialaccountingstandardsprovidedpursuanttoSection13(a)oftheExchangeAct.☐ Indicatebycheckmarkwhethertheregistranthasfiledareportonandattestationtoitsmanagement’sassessmentoftheeffectivenessofitsinternalcontroloverfinancialreportingunderSection404(b)oftheSarbanes-OxleyAct(15U.S.C.7262(b))bytheregisteredpublicaccountingfirmthatpreparedorissueditsauditreport.☐ IfsecuritiesareregisteredpursuanttoSection12(b)oftheAct,indicatebycheckmarkwhetherthefinancialstatementsoftheregistrantincludedinthefilingreflectthecorrectionofanerrortopreviouslyissuedfinancialstatements.☐ Indicatebycheckmarkwhetheranyofthoseerrorcorrectionsarerestatementsthatrequiredarecoveryanalysisofincentive-basedcompensationreceivedbyanyoftheregistrant’sexecutiveofficersduringtherelevantrecoveryperiodpursuantto§240.10D-1(b).☐ Indicatebycheckmarkwhichbasisofaccountingtheregistranthasusedtopreparethefinancialstatementsincludedinthisfiling: U.S.GAAP☒InternationalFinancialReportingStandardsasissuedbythe InternationalAccountingStandardsBoard☐ Other☐ If“Other”hasbeencheckedinresponsetothepreviousquestion,indicatebycheckmarkwhichfinancialstatementitemtheregistranthaselectedtofollow.☐Item17☐Item18 Ifthisisanannualreport,indicatebycheckmarkwhethertheregistrantisashellcompany(asdefinedinRule12b-2oftheExchangeAct).Yes☐No☒ AnnualReportonForm20-FYearEndedDecember31,2022 TABLEOFCONTENTS Page PARTI 1 ITEM1. IDENTITYOFDIRECTORS,SENIORMANAGEMENTANDADVISERS 1 ITEM2. OFFERSTATISTICSANDEXPECTEDTIMETABLE 1 ITEM3. KEYINFORMATION 1 ITEM4. INFORMATIONONTHECOMPANY 28 ITEM4A. UNRESOLVEDSTAFFCOMMENTS 71 ITEM5. OPERATINGANDFINANCIALREVIEWANDPROSPECTS 72 ITEM6. DIRECTORS,SENIORMANAGEMENTANDEMPLOYEES 84 ITEM7. MAJORSHAREHOLDERSANDRELATEDPARTYTRANSACTIONS 91 ITEM8. FINANCIALINFORMATION 92 ITEM9. THEOFFERANDLISTING 92 ITEM10. ADDITIONALINFORMATION 93 ITEM11. QUANTITATIVEANDQUALITATIVEDISCLOSURESABOUTMARKETRISK 101 ITEM12. DESCRIPTIONOFSECURITIESOTHERTHANEQUITYSECURITIES 102 PARTII 103 ITEM13. DEFAULTS,DIVIDENDARREARAGESANDDELINQU